Poland· PL-100532530
Dawnzera
A drugs used in hereditary angioedema product containing donidalorsen, registered in Poland by Otsuka Pharmaceutical Netherlands B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Donidalorsen is registered in 2 of 19 countries.
Countries holding a registration under ATC B06AC (drugs used in hereditary angioedema), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 1 of them publish a price we can compare per daily dose
Donidalorsen · ATC B06AC
2 / 19 countries
- Denmark
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Donidalorsen
- Manufacturer
- Otsuka Pharmaceutical Netherlands B.V.
- Country
- Poland (PL)
- ATC code
- B06AC
- ATC class
- Drugs used in hereditary angioedema
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05038256003587
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Donidalorsen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandDawnzera 80 mg, InjektionslösungOtsuka Pharmaceutical (Switzerland) GmbH
- SpainDAWNZERA 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAOtsuka Pharmaceutical Netherlands B.V.
- NorwayDawnzeraOtsuka Pharmaceutical Netherlands B.V.
- SwedenDawnzera 80 mg Injektionsvätska, lösning i förfylld injektionspennaOtsuka Pharmaceutical Netherlands B.V.
- NetherlandsDawnzera 80 mg oplossing voor injectie in een voorgevulde penOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dawnzera
- Liechtenstein · Dawnzera
- Norway · Dawnzera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad5a1521-d51b-485c-9d57-59445b0fcb6c GET /v1/drugs/ad5a1521-d51b-485c-9d57-59445b0fcb6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "80 mg",
"packaging": "05038256003587 ¦ Rpz ¦ EU/1/25/2001/001 ¦ 165687\n1 wstrzyk. 0,8 ml\nRpz ¦ EU/1/25/2001/002 ¦ 165688\n3 wstrzyk. 0,8 ml",
"substance": "Donidalorsen 80 mg",
"common_name": "Donidalorsen",
"pl_product_id": "100532530",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about donidalorsen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.